ATG Prevents Severe Acute Graft-versus-Host Disease in Mismatched Unrelated Donor Hematopoietic Cell Transplantation

Lignende værker

• Sirolimus demonstrates activity in the primary therapy of acute graft-versus-host disease without systemic glucocorticoids
  af: Pidala, Joseph, et al.
  Udgivet: (2011)
• Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization
  af: Pidala, J, et al.
  Udgivet: (2012)
• Sirolimus, tacrolimus and antithymocyte globulin as GVHD prophylaxis in HLA-mismatched unrelated donor hematopoietic cell transplantation: a single institution experience
  af: Nelson, R, et al.
  Udgivet: (2015)
• Phase II Study of CD4(+)-Guided Pentostatin Lymphodepletion and Pharmacokinetically Targeted Busulfan as Conditioning for Hematopoietic Cell Allografting
  af: Kharfan-Dabaja, Mohamed A., et al.
  Udgivet: (2013)
• Targeted IV busulfan and fludarabine followed by post-allogeneic hematopoietic cell transplantation rituximab demonstrate encouraging activity in CD20+ lymphoid malignancies without increased risk of infectious complications
  af: Pidala, Joseph, et al.
  Udgivet: (2011)